Analysts Set Health Catalyst, Inc. (NASDAQ:HCAT) Price Target at $2.77

Health Catalyst, Inc. (NASDAQ:HCAT) has received an average rating of “Hold” from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $2.7727.

Several research analysts recently issued reports on the company. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $1.00 target price (down from $5.00) on shares of Health Catalyst in a research report on Wednesday, March 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Health Catalyst in a research report on Friday, March 27th. Stephens cut their price objective on Health Catalyst from $2.00 to $1.75 and set an “equal weight” rating on the stock in a research report on Tuesday, May 12th. Raymond James Financial set a $3.00 price objective on Health Catalyst in a research report on Friday, March 13th. Finally, Cantor Fitzgerald reissued a “neutral” rating on shares of Health Catalyst in a research report on Monday, May 11th.

Health Catalyst Trading Up 45.9%

Shares of HCAT stock opened at $1.94 on Friday. The company has a market cap of $143.35 million, a P/E ratio of -0.52 and a beta of 1.66. The stock has a 50 day simple moving average of $1.29 and a two-hundred day simple moving average of $1.85. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.69 and a current ratio of 1.69. Health Catalyst has a fifty-two week low of $0.96 and a fifty-two week high of $4.29.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings data on Monday, May 11th. The company reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01. Health Catalyst had a negative return on equity of 3.52% and a negative net margin of 87.69%.The firm had revenue of $70.76 million during the quarter, compared to analysts’ expectations of $69.24 million. Research analysts forecast that Health Catalyst will post -0.25 earnings per share for the current year.

Institutional Trading of Health Catalyst

Several hedge funds have recently made changes to their positions in the company. First Light Asset Management LLC raised its stake in shares of Health Catalyst by 9.9% in the third quarter. First Light Asset Management LLC now owns 13,436,220 shares of the company’s stock valued at $38,293,000 after buying an additional 1,206,039 shares during the period. Vanguard Group Inc. raised its stake in shares of Health Catalyst by 2.9% in the third quarter. Vanguard Group Inc. now owns 4,295,691 shares of the company’s stock valued at $12,243,000 after buying an additional 119,117 shares during the period. Whetstone Capital Advisors LLC raised its stake in shares of Health Catalyst by 0.5% in the fourth quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock valued at $8,963,000 after buying an additional 19,027 shares during the period. Nepsis Inc. raised its stake in shares of Health Catalyst by 26.6% in the fourth quarter. Nepsis Inc. now owns 1,915,794 shares of the company’s stock valued at $4,579,000 after buying an additional 402,762 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Health Catalyst by 11.4% in the second quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock valued at $6,269,000 after buying an additional 169,580 shares during the period. 85.00% of the stock is currently owned by institutional investors.

Health Catalyst Company Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.